Cargando…

COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control

Background: COVID-19 vaccination has been recommended for severe asthmatics. We aimed to evaluate the safety, tolerability, and impact on disease control and patient’s quality of life of the mRNA SARS-CoV-2/COVID-19 vaccine in severe asthma patients regarding biologic treatment. Methods: Severe asth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caminati, Marco, Guarnieri, Gabriella, Batani, Veronica, Scarpieri, Elena, Finocchiaro, Anita, Chieco-Bianchi, Fulvia, Senna, Gianenrico, Vianello, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402597/ https://www.ncbi.nlm.nih.gov/pubmed/34451978 http://dx.doi.org/10.3390/vaccines9080853

Ejemplares similares

Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
por: Guarnieri, Gabriella, et al.
Publicado: (2022)

Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry
por: Caminati, Marco, et al.
Publicado: (2022)

Clinical response to biologicals for severe asthma: any relevance for sex in different age ranges?
por: Benoni, Roberto, et al.
Publicado: (2022)

Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity
por: Caminati, Marco, et al.
Publicado: (2021)

Uncontrolled Asthma: Unmet Needs in the Management of Patients
por: Caminati, Marco, et al.
Publicado: (2021)

Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
por: Guarnieri, Gabriella, et al.
Publicado: (2022)

Biologics and anti-Sars Cov2 vaccination in severe asthma riding the big wave: Unity is strength!
por: Guarnieri, G., et al.
Publicado: (2022)

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
por: Caminati, Marco, et al.
Publicado: (2019)

Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
por: Caminati, Marco, et al.
Publicado: (2021)

Targeting eosinophils: severe asthma and beyond
por: Caminati, Marco, et al.
Publicado: (2019)

Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach
por: Maule, Matteo, et al.
Publicado: (2023)

Oral health in asthmatic patients: a review: Asthma and its therapy may impact on oral health
por: Gani, Federica, et al.
Publicado: (2020)

Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
por: Caminati, M., et al.
Publicado: (2016)

Relative Humidity and Its Impact on the Immune System and Infections
por: Guarnieri, Gabriella, et al.
Publicado: (2023)

Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses
por: Vianello, Andrea, et al.
Publicado: (2021)

The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
por: Furci, Fabiana, et al.
Publicado: (2021)

Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
por: Caminati, Marco, et al.
Publicado: (2020)

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance
por: Caminati, Marco, et al.
Publicado: (2023)

Upsides and downsides of a telecounselling model of integrated asthma management between general practitioners and specialists
por: Furci, Fabiana, et al.
Publicado: (2022)

Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective
por: Caminati, Marco, et al.
Publicado: (2023)

Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI
por: Senna, Gianenrico, et al.
Publicado: (2020)

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
por: Puggioni, Francesca, et al.
Publicado: (2020)

Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience
por: Vianello, A., et al.
Publicado: (2019)

Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy
por: Tognella, Silvia, et al.
Publicado: (2021)

Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy
por: Caminati, Marco, et al.
Publicado: (2019)

Fatal asthma; is it still an epidemic?
por: Vianello, Andrea, et al.
Publicado: (2016)

Therapeutic interventions in severe asthma
por: Canonica, Giorgio Walter, et al.
Publicado: (2016)

TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD
por: Furci, Fabiana, et al.
Publicado: (2023)

SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
por: Senna, G., et al.
Publicado: (2017)

Asthma under/misdiagnosis in primary care setting: an observational community-based study in Italy
por: Magnoni, Maria Sandra, et al.
Publicado: (2015)

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
por: Canonica, Giorgio Walter, et al.
Publicado: (2020)

The intriguing possibility of using probiotics in allergen-specific immunotherapy
por: Furci, Fabiana, et al.
Publicado: (2023)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain
por: Magnoni, Maria Sandra, et al.
Publicado: (2017)

Biologics and global burden of asthma: A worldwide portrait and a call for action
por: Caminati, M., et al.
Publicado: (2021)

Management of the patient with allergic and immunological disorders in the pandemic COVID-19 era
por: Patella, Vincenzo, et al.
Publicado: (2020)

Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly
por: Scichilone, Nicola, et al.
Publicado: (2015)

The “Asthma-Polycystic Ovary Overlap Syndrome” and the Therapeutic Role of Myo-Inositol
por: Guarnieri, Gabriella, et al.
Publicado: (2023)

Asthmatic patients in COVID-19 outbreak: Few cases despite many cases
por: Caminati, Marco, et al.
Publicado: (2020)

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
por: Varricchi, Gilda, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v67oe8djaatn9tjut22e5ikpir